Andres Briseno
Director of Finance/CFO bij IDEAYA BIOSCIENCES, INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Andres Ruiz Briseno is currently the Senior VP, Head-Finance & Investor Relations at IDEAYA Biosciences, Inc. He previously worked as the Associate Director-Financial Planning & Analysis at Pharmacyclics LLC from 2013 to 2016.
Andres completed his undergraduate degree at San Jose State University in 2009.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IDEAYA BIOSCIENCES, INC.
0.03% | 01-03-2024 | 24 531 ( 0.03% ) | 1 M $ | 31-03-2024 |
Actieve functies van Andres Briseno
| Bedrijven | Functie | Begin |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Director of Finance/CFO | 01-07-2023 |
Eerdere bekende functies van Andres Briseno
| Bedrijven | Functie | Einde |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01-08-2016 |
Opleiding van Andres Briseno
| San Jose State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IDEAYA BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
